Moneycontrol PRO
HomeNewsTrendsHealthKazakhstan denies Chinese reports of 'unknown pneumonia' deadlier than coronavirus

Kazakhstan denies Chinese reports of 'unknown pneumonia' deadlier than coronavirus

China has warned its citizens living in Kazakhstan of a local "unknown pneumonia" which, it said, has a "much higher" fatality rate than COVID-19. Kazakhstan has branded this as "fake news".

July 10, 2020 / 13:24 IST
Representative image

Kazakhstan, on July 10, dismissed Chinese reports of 'unknown pneumonia' deadlier than the novel coronavirus.

China has warned its citizens living in Kazakhstan of a local "unknown pneumonia" which, it said, has a "much higher" fatality rate than COVID-19.

The "unknown pneumonia in Kazakhstan caused 1,772 deaths in the first six months of the year, including 628 people in June alone", the Chinese embassy in the central Asian country said in a statement on its WeChat platform on July 9, adding that the fatalities also included Chinese citizens.

“The fatality rate of the disease is much higher than COVID-19," state-run Global Times quoted the embassy's statement on July 10.

Many organisations including Kazakhstan's health department are studying the "virus of this pneumonia", the embassy said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

There has not been any indication whether this disease is related to the COVID-19.

Some Chinese experts said that measures should be taken to prevent the pneumonia from spreading into China. Kazakhstan borders China's northwest Xinjiang Uygur Autonomous Region.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Kazakhstan rejects Chinese claims

Kazakhstan's healthcare ministry branded Chinese media reports based on the embassy statement as "fake news". The ministry said its tallies of bacterial, fungal and  viral pneumonia infections, which also included cases of unclear causes, were in line with World Health Organization (WHO) guidelines.

"The information published by some Chinese media regarding a new kind of pneumonia in Kazakhstan is incorrect," the ministry said.

Kazakhstan, which imposed a second lockdown this week to rein in the pandemic, has a tally of almost 55,000 COVID-19 infections, including 264 deaths. The number of new cases rose on Thursday to a daily record of 1,962.

On July 7, state news agency Kazinform had said the number of pneumonia cases "increased 2.2 times in June as compared to the same period of 2019".

(With inputs from PTI and Reuters)

Click here for Moneycontrol’s full coverage of the novel coronavirus pandemic

Moneycontrol News
first published: Jul 10, 2020 01:23 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347